G47.32: High altitude periodic breathing
G47.32, high altitude periodic breathing, is listed as a covered diagnosis in 3 Medicare billing and coding articles that apply to 22 HCPCS Level II codes, including G0399 (Home sleep test (hst) with type iii portable monitor…), G0400 (Home sleep test (hst) with type iv portable monitor…), G0398 (Home sleep study test (hst) with type ii portable monitor…). The articles come from 3 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with G47.32 as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Carrier judgment | — | 2 |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Carrier judgment | — | 2 |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Carrier judgment | — | 2 |
| J2785 | Injection, regadenoson, 0.1 mg | Carrier judgment | — | 1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | Special coverage instructions apply | — | 1 |
| J3490 | Unclassified drugs | Special coverage instructions apply | — | 1 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Special coverage instructions apply | — | 1 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Carrier judgment | — | 1 |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | Special coverage instructions apply | — | 1 |
| J0280 | Injection, aminophyllin, up to 250 mg | Special coverage instructions apply | — | 1 |
| J1245 | Injection, dipyridamole, per 10 mg | Special coverage instructions apply | — | 1 |
| Q9956 | Injection, octafluoropropane microspheres, per ml | Carrier judgment | — | 1 |
| C9399 | Unclassified drugs or biologicals | Special coverage instructions apply | — | 1 |
| A9700 | Supply of injectable contrast material for use in echocardiography, per study | Special coverage instructions apply | — | 1 |
| C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete | Special coverage instructions apply | — | 1 |
| C8922 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study | Special coverage instructions apply | — | 1 |
| C8923 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography | Special coverage instructions apply | — | 1 |
| C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study | Special coverage instructions apply | — | 1 |
| C8928 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report | Special coverage instructions apply | — | 1 |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | Special coverage instructions apply | — | 1 |
| C8930 | Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision | Special coverage instructions apply | — | 1 |
| Q9955 | Injection, perflexane lipid microspheres, per ml | Carrier judgment | — | 1 |
Medicare policy articles listing G47.32
- A56903: Billing and Coding: Polysomnography and Other Sleep Studies (WPS Insurance Corporation (MAC - Part A, MAC - Part B); 3 Level II codes). LCD with the same title: L36839, L36861, L36902
- A56923: Billing and Coding: Outpatient Sleep Studies (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B); 3 Level II codes). LCD with the same title: L35050
- A57306: Billing and Coding: Transthoracic Echocardiography (TTE) (CGS Administrators, LLC (MAC - Part A, MAC - Part B); 19 Level II codes). LCD with the same title: L33577, L34338
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other G47 diagnoses (Sleep disorders)
- G47.30 — Sleep apnea, unspecified
- G47.31 — Primary central sleep apnea
- G47.33 — Obstructive sleep apnea (adult) (pediatric)
- G47.34 — Idiopathic sleep related nonobstructive alveolar hypoventilation
- G47.35 — Congenital central alveolar hypoventilation syndrome
- G47.36 — Sleep related hypoventilation in conditions classified elsewhere
- G47.37 — Central sleep apnea in conditions classified elsewhere
- G47.39 — Other sleep apnea
- G47.10 — Hypersomnia, unspecified
- G47.11 — Idiopathic hypersomnia with long sleep time
- G47.12 — Idiopathic hypersomnia without long sleep time
- G47.13 — Recurrent hypersomnia
- G47.14 — Hypersomnia due to medical condition
- G47.19 — Other hypersomnia
- G47.411 — Narcolepsy with cataplexy
- G47.419 — Narcolepsy without cataplexy
- G47.421 — Narcolepsy in conditions classified elsewhere with cataplexy
- G47.429 — Narcolepsy in conditions classified elsewhere without cataplexy
- G47.50 — Parasomnia, unspecified
- G47.51 — Confusional arousals
- G47.52 — REM sleep behavior disorder
- G47.53 — Recurrent isolated sleep paralysis
- G47.54 — Parasomnia in conditions classified elsewhere
- G47.59 — Other parasomnia
- G47.61 — Periodic limb movement disorder
- G47.8 — Other sleep disorders
- G47.9 — Sleep disorder, unspecified
Frequently asked questions
Does Medicare cover G47.32 (High altitude periodic breathing)?
Medicare covers items and services, not diagnoses. 3 Medicare billing and coding articles list G47.32 as a covered diagnosis for 22 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 G47.32?
The Level II codes from the policies most specific to this diagnosis are G0399 (Home sleep test (hst) with type iii portable monitor…, 2 articles); G0400 (Home sleep test (hst) with type iv portable monitor…, 2 articles); G0398 (Home sleep study test (hst) with type ii portable monitor…, 2 articles); J2785 (Injection, regadenoson, 0.1 mg, 1 article); J0461 (Injection, atropine sulfate, 0.01 mg, 1 article). Code choice depends on the item supplied; check each code's descriptor.
Which Medicare policy articles list G47.32?
A56903 (Billing and Coding: Polysomnography and Other Sleep Studies); A56923 (Billing and Coding: Outpatient Sleep Studies); A57306 (Billing and Coding: Transthoracic Echocardiography (TTE)).
What is ICD-10-CM code G47.32?
G47.32 is the ICD-10-CM code for high altitude periodic breathing, in category G47 (Sleep disorders), chapter 6: Diseases of the nervous system.
Next steps
- Run a reimbursement report for a device billed under G0399
- Watch G0399 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for G0399
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.
Chapter 6: Diseases of the nervous system · All diagnoses · HCPCS lookup